Literature DB >> 21334601

Retinoid x receptor gamma is implicated in docosahexaenoic acid modulation of despair behaviors and working memory in mice.

Marta Wietrzych-Schindler1, Monika Szyszka-Niagolov, Kiminori Ohta, Yasuyuki Endo, Efrén Pérez, Angel R de Lera, Pierre Chambon, Wojciech Krezel.   

Abstract

BACKGROUND: Omega-3 polyunsaturated fatty acids, including docosahexaenoic acid (DHA), have antidepressant and promnemonic functions. The mechanisms of such activities are still elusive and may involve retinoid X receptors (RXRs), transcription factors known to bind DHA in vitro.
METHODS: Promnemonic and antidespair activities of acute DHA treatment were tested in BALBcByJ mice using spontaneous alternation and forced swim test, respectively. The involvement of retinoid receptors in such DHA activities was investigated using RXR and/or retinoic acid receptor (RAR) agonists to mimic DHA activities or a synthetic pan-RXR antagonist to block them. Involvement of RXR isotypes was analyzed using the same tasks and delayed nonmatch to place for working memory in RXRγ knockout mice.
RESULTS: Docosahexaenoic acid decreased despair behavior and improved working memory in BALBcByJ mice. Such effects were suppressed by co-treatment with BR1211, a pan-RXR antagonist, whereas a pan-RXR agonist, UVI2108, mimicked DHA activities. Retinoic acid (RA), a natural ligand of RXRs, also reduced despair behavior and improved working memory and such activities did not require activation of RARs, as RA effects were abolished by co-treatment with BR1211 and they were not reproduced by TTNPB, a pan-RAR agonist. The RXRγ knockout mice displayed increased despair and deficits in working memory, which were insensitive to DHA and pan-RXR agonist treatments, whereas DHA or UVI2108 reversed these deficits in RXRγ heterozygous mice.
CONCLUSIONS: Our data suggest that RXRs are a converging point in mediating DHA and RA modulations of despair behavior and working memory and that RXRγ is the predominant RXR isotype in these regulations.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21334601     DOI: 10.1016/j.biopsych.2010.12.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  18 in total

Review 1.  A review of the molecular design and biological activities of RXR agonists.

Authors:  Nathalia Rodrigues de Almeida; Martin Conda-Sheridan
Journal:  Med Res Rev       Date:  2019-04-03       Impact factor: 12.944

2.  Genome-wide Analysis of RARβ Transcriptional Targets in Mouse Striatum Links Retinoic Acid Signaling with Huntington's Disease and Other Neurodegenerative Disorders.

Authors:  Anna Niewiadomska-Cimicka; Agnieszka Krzyżosiak; Tao Ye; Anna Podleśny-Drabiniok; Doulaye Dembélé; Pascal Dollé; Wojciech Krężel
Journal:  Mol Neurobiol       Date:  2016-07-12       Impact factor: 5.590

3.  Direct inhibition of retinoic acid catabolism by fluoxetine.

Authors:  Julian Hellmann-Regen; Ria Uhlemann; Francesca Regen; Isabella Heuser; Christian Otte; Matthias Endres; Karen Gertz; Golo Kronenberg
Journal:  J Neural Transm (Vienna)       Date:  2015-05-17       Impact factor: 3.575

Review 4.  Mechanisms of gene regulation by fatty acids.

Authors:  Anastasia Georgiadi; Sander Kersten
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

Review 5.  Retinoid X Receptor: Cellular and Biochemical Roles of Nuclear Receptor with a Focus on Neuropathological Involvement.

Authors:  Samridhi Sharma; Ting Shen; Nitin Chitranshi; Veer Gupta; Devaraj Basavarajappa; Soumalya Sarkar; Mehdi Mirzaei; Yuyi You; Wojciech Krezel; Stuart L Graham; Vivek Gupta
Journal:  Mol Neurobiol       Date:  2022-01-11       Impact factor: 5.682

6.  9-cis-13,14-Dihydroretinoic Acid Is an Endogenous Retinoid Acting as RXR Ligand in Mice.

Authors:  Ralph Rühl; Agnieszka Krzyżosiak; Anna Niewiadomska-Cimicka; Natacha Rochel; Lajos Szeles; Belén Vaz; Marta Wietrzych-Schindler; Susana Álvarez; Monika Szklenar; Laszlo Nagy; Angel R de Lera; Wojciech Krężel
Journal:  PLoS Genet       Date:  2015-06-01       Impact factor: 5.917

7.  EPA/DHA and Vitamin A Supplementation Improves Spatial Memory and Alleviates the Age-related Decrease in Hippocampal RXRγ and Kinase Expression in Rats.

Authors:  Anne Létondor; Benjamin Buaud; Carole Vaysse; Emmanuel Richard; Sophie Layé; Véronique Pallet; Serge Alfos
Journal:  Front Aging Neurosci       Date:  2016-05-09       Impact factor: 5.750

Review 8.  Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

Authors:  Christian Knöchel; Martin Voss; Florian Grüter; Gilberto S Alves; Silke Matura; Beate Sepanski; Michael Stäblein; Sofia Wenzler; David Prvulovic; André F Carvalho; Viola Oertel-Knöchel
Journal:  Curr Neuropharmacol       Date:  2015       Impact factor: 7.363

9.  Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes.

Authors:  M Maekawa; A Watanabe; Y Iwayama; T Kimura; K Hamazaki; S Balan; H Ohba; Y Hisano; Y Nozaki; T Ohnishi; M Toyoshima; C Shimamoto; K Iwamoto; M Bundo; N Osumi; E Takahashi; A Takashima; T Yoshikawa
Journal:  Transl Psychiatry       Date:  2017-09-05       Impact factor: 6.222

10.  Systematic review of the literature on vitamin A and memory.

Authors:  Yara Dadalti Fragoso; Niklas Söderberg Campos; Breno Faria Tenrreiro; Fernanda Jussio Guillen
Journal:  Dement Neuropsychol       Date:  2012 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.